Literature DB >> 16344570

Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?

S Ghosh1, R Chaudhary, M Carpani, R J Playford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16344570      PMCID： PMC1856379          DOI： 10.1136/gut.2005.074401

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  23 in total

1.  Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial.

Authors:  A Sood; V Midha; N Sood; V Kaushal
Journal:  Indian J Gastroenterol       Date:  2000 Jan-Mar

2.  The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.

Authors:  A G Fraser; T R Orchard; D P Jewell
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

3.  6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease.

Authors:  J Maté-Jiménez; C Hermida; J Cantero-Perona; R Moreno-Otero
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-11       Impact factor: 2.566

4.  Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.

Authors:  S Ardizzone; G Maconi; A Russo; V Imbesi; E Colombo; G Bianchi Porro
Journal:  Gut       Date:  2005-06-21       Impact factor: 23.059

5.  The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.

Authors:  A G Fraser; D Morton; D McGovern; S Travis; D P Jewell
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

6.  Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience.

Authors:  Z H Khan; J F Mayberry; N Spiers; A C Wicks
Journal:  Digestion       Date:  2000       Impact factor: 3.216

7.  Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.

Authors:  Gert Van Assche; Geert D'Haens; Maja Noman; Séverine Vermeire; Martin Hiele; Katrien Asnong; Joris Arts; Andre D'Hoore; Freddy Penninckx; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

8.  Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.

Authors:  D P Jewell; S C Truelove
Journal:  Br Med J       Date:  1974-12-14

9.  Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome.

Authors:  S Campbell; S Ghosh
Journal:  Dig Liver Dis       Date:  2003-08       Impact factor: 4.088

10.  Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.

Authors:  O A Paoluzi; R Pica; A Marcheggiano; P Crispino; F Iacopini; C Iannoni; M Rivera; P Paoluzi
Journal:  Aliment Pharmacol Ther       Date:  2002-10       Impact factor: 8.171
View more
  3 in total

1.  Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.

Authors:  Javier P Gisbert; María Chaparro; Fernando Gomollón
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

Review 2.  Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

Authors:  Gerda C Leitner; Harald Vogelsang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

3.  Usefulness of salicylate and thiopurine coprescription in steroid-dependent ulcerative colitis and withdrawal strategies.

Authors:  Fernando Bermejo; Javier P Gisbert
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.